351 related articles for article (PubMed ID: 35203604)
1. Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment.
Jiang YH; Jhang JF; Lee YK; Kuo HC
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203604
[TBL] [Abstract][Full Text] [Related]
2. Low energy shock wave-delivered intravesical botulinum neurotoxin-A potentiates antioxidant genes and inhibits proinflammatory cytokines in rat model of overactive bladder.
Nageib M; Zahran MH; El-Hefnawy AS; Barakat N; Awadalla A; Aamer HG; Khater S; Shokeir AA
Neurourol Urodyn; 2020 Nov; 39(8):2447-2454. PubMed ID: 32960981
[TBL] [Abstract][Full Text] [Related]
3. The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis.
Jiang YH; Jhang JF; Kuo HC
Tzu Chi Med J; 2023; 35(1):31-37. PubMed ID: 36866354
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
5. Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders.
Jhang JF; Kuo HC
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069951
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effect of Botulinum Toxin A on Sensory Bladder Disorders-From Bench to Bedside.
Jiang YH; Yu WR; Kuo HC
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32182780
[TBL] [Abstract][Full Text] [Related]
7. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jhang JF; Kuo HC
Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393152
[TBL] [Abstract][Full Text] [Related]
8. Low energy shock wave therapy attenuates mitochondrial dysfunction and improves bladder function in HCl induced cystitis in rats.
Wang HJ; Tyagi P; Lin TK; Huang CC; Lee WC; Chancellor MB; Chuang YC
Biomed J; 2022 Jun; 45(3):482-490. PubMed ID: 34224911
[TBL] [Abstract][Full Text] [Related]
9. New Frontiers of Extracorporeal Shock Wave Medicine in Urology from Bench to Clinical Studies.
Chen PY; Cheng JH; Wu ZS; Chuang YC
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327477
[TBL] [Abstract][Full Text] [Related]
10. Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders.
Hung FC; Kuo HC
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548734
[TBL] [Abstract][Full Text] [Related]
11. Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jiang YH; Jhang JF; Chang WC; Kuo HC
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548768
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
13. Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.
Jhang JF
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31689912
[TBL] [Abstract][Full Text] [Related]
14. Effects of low energy shock wave therapy on inflammatory moleculars, bladder pain, and bladder function in a rat cystitis model.
Wang HJ; Lee WC; Tyagi P; Huang CC; Chuang YC
Neurourol Urodyn; 2017 Aug; 36(6):1440-1447. PubMed ID: 28035695
[TBL] [Abstract][Full Text] [Related]
15. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
16. Effect of low-energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer.
Elkashef A; Barakat N; Khater SM; Awadalla A; Belal F; El-Assmy AM; Sheir KZ; Shokeir AA
BJU Int; 2021 Jan; 127(1):80-89. PubMed ID: 32654305
[TBL] [Abstract][Full Text] [Related]
17. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
18. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
Chiu B; Tai HC; Chung SD; Birder LA
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
[TBL] [Abstract][Full Text] [Related]
19. Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome.
Li H; Zhang Z; Peng J; Xin Z; Li M; Yang B; Fang D; Tang Y; Guo Y
Investig Clin Urol; 2019 Sep; 60(5):359-366. PubMed ID: 31501798
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis.
Chen JL; Kuo HC
Investig Clin Urol; 2020 Feb; 61(Suppl 1):S33-S42. PubMed ID: 32055752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
